Uniphar Group PLC (UPR) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally.
Total Cash From Operating Activities Chart for Uniphar Group PLC
Uniphar Group PLC (UPR) operating cash flow for FY2025 was EUR 108.4M, a -12.7% change from FY2024. Uniphar Group PLC's operating cash flow grew from EUR 23.7M in 2016 to EUR 108.4M in 2025 (357.6% over 9 years). Operating cash flow compound annual growth rate: 5-year CAGR of 10.4%.
Total Cash From Operating Activities (Euros)
R&D as % of Revenue
Key Stats
- Market Cap
- €1.11B
- Implied Share Price
- €4.29
- Enterprise Value
- €1.44B
- Revenue (TTM)
- €3.07B
- EBITDA
- €107.44M
- Profit Margin
- 1.66%
- Trailing P/E
- 21.45
- Forward P/E
- 16.31
- Price/Book (MRQ)
- 2.74
- Price/Sales (TTM)
- 0.36
- EV/EBITDA
- 12.00
- EV/Revenue
- 0.47
- Dividend Yield
- 0.47%
- Book Value
- €1.56
- Free Cash Flow (FY2025)
- €45.61M
- Free Cash Flow Yield
- 4.10%
Snapshot as of 15th August 2026 — not point-in-time controlled, may lag the live market by a few days.